As of 2026-05-25, the Fair Value of Cytogen Inc (217330.KQ) is -3,292.47 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4,800.00 KRW, the upside of Cytogen Inc is -168.59%.
With the market price of 4,800.00 KRW and our fair value calculation, Cytogen Inc (217330.KQ) is not a good investment. Investing in 217330.KQ stocks now will result in a potential loss of 168.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -4,888.80 | -10,870.61 | -18,771.23 | -15,769.50 | -17,116.99 | -13,483.43 |
| YoY growth | -18.06% | -122.36% | -72.68% | 15.99% | -8.54% | -41.13% |
| Market Cap (mil) | 111,024.00 |
| P/E | |
| Forward P/E |
| EPS | -658.49 |
| Avg earnings growth rate | -41.13% |
| TTM earnings | -15,230.97 |